Wijburg O L, Simmons C P, van Rooijen N, Strugnell R A
Department of Microbiology and Immunology, The University of Melbourne, Australia.
Eur J Immunol. 2000 Mar;30(3):944-53. doi: 10.1002/1521-4141(200003)30:3<944::AID-IMMU944>3.0.CO;2-1.
Salmonella spp. are regarded as facultative intracellular bacterial pathogens which are found inside macrophages (Mphi) after i. v. infection. It is generally assumed that Mphi restrict the replication of the bacteria during infection. In this study we examined the in vivo activities of Mphi during experimental S. typhimurium infections, using a selective liposome-based Mphi elimination technique. Unexpectedly, elimination of Mphi prior to infection with virulent S. typhimurium decreased morbidity and mortality, suggesting that Mphi mediate the pathology caused by S. typhimurium. Removal of Mphi) during vaccination with attenuated S. typhimurium did not affect protection against challenge with virulent S. typhimurium, suggesting that Mphi are not required for the induction of protective immunity and that other cells must function as antigen-presenting cell to elicit T cell-mediated protection. However, Mphi appeared to be important effectors of protection against challenge infection since elimination of Mphi from vaccinated mice prior to challenge infection with virulent S. typhimurium significantly decreased protection. These results enhance our understanding of the control of S. typhimurium growth in vivo, and moreover suggest that Mphi play a major role in the pathology of virulent S. typhimurium infections. As such, these cells may present a novel target for therapeutic intervention.
沙门氏菌属被视为兼性胞内细菌病原体,静脉注射感染后可在巨噬细胞(Mphi)内发现。一般认为,巨噬细胞在感染期间会限制细菌的复制。在本研究中,我们使用基于脂质体的选择性巨噬细胞清除技术,检测了实验性鼠伤寒沙门氏菌感染期间巨噬细胞的体内活性。出乎意料的是,在用强毒鼠伤寒沙门氏菌感染之前清除巨噬细胞,可降低发病率和死亡率,这表明巨噬细胞介导了鼠伤寒沙门氏菌引起的病理过程。在用减毒鼠伤寒沙门氏菌疫苗接种期间清除巨噬细胞,并不影响对强毒鼠伤寒沙门氏菌攻击的保护作用,这表明诱导保护性免疫不需要巨噬细胞,其他细胞必定作为抗原呈递细胞发挥作用以引发T细胞介导的保护作用。然而,巨噬细胞似乎是抵抗攻击感染的重要效应细胞,因为在用强毒鼠伤寒沙门氏菌攻击感染之前,从接种疫苗的小鼠体内清除巨噬细胞会显著降低保护作用。这些结果增进了我们对鼠伤寒沙门氏菌在体内生长控制的理解,此外还表明巨噬细胞在强毒鼠伤寒沙门氏菌感染的病理过程中起主要作用。因此,这些细胞可能是治疗干预的新靶点。